US Stocks Sink; Nasdaq 100 and Dow Industrials Enter Correction



(Bloomberg) — The selloff in US stocks accelerated on Friday, as traders fled equities on fears that a surge in oil prices sparked by the escalating Iran war will cripple the global economy.  Read More



Source link

  • Related Posts

    AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

    Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality…

    Session 14 (Francis Annan, Virginia Minni and Tommaso Porzio) – STEG-PEDL Virtual Course on ‘Private Enterprises, Productivity, and Economic Growth’

    Course Description: Perhaps the central question of economic development and structural transformation is how to increase productivity. As economies move out of agriculture, this question naturally hinges on the major private-sector…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Morocco claims AFCON case closed, despite Senegal appeals to CAF and CAS | Football News

    Morocco claims AFCON case closed, despite Senegal appeals to CAF and CAS | Football News

    Two Iowans accused of lacing lasagna with drugs to cause woman’s miscarriage | Iowa

    Two Iowans accused of lacing lasagna with drugs to cause woman’s miscarriage | Iowa

    UFC brings cage-match bout to the White House, home of a president who favors cage-match politics

    UFC brings cage-match bout to the White House, home of a president who favors cage-match politics

    Anthropic’s Claude popularity with paying consumers is skyrocketing

    Anthropic’s Claude popularity with paying consumers is skyrocketing

    The Thousand and One Nights – Scripturient

    AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis